Sanara invests $5M for 6.6% of ChemoMouthpiece, exclusive U.S. distribution via InfuSystem JV

Sanara MedTech Inc.

Sanara CMP purchased 100,674.72 common units in ChemoMouthpiece for $5.0 million, a 6.64% ownership stake.
SI Technologies (50/50 JV with InfuSystem) appointed sole U.S. distributor of ChemoMouthpiece kits for 5 years.
SI Technologies has an option to purchase ChemoMouthpiece's U.S. business, including IP, expiring Jan 31, 2029.
Sanara borrowed an additional $15.5M under its CRG term loan at 13.25% per annum, maturing May 30, 2029.
Proceeds used for the ChemoMouthpiece investment; remaining funds for acquisitions and working capital.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.